 Ginkgo Bioworks is, along with Amyris, the leader in synthetic biology. A one-of-a-kind business model, solid technology and platform, a wide range of markets and applications, compounding potential, a reasonable valuation, and minimal cash burn, make Ginkgo attractive. 